GDm-Health is a digital therapeutic for remotely managing pregnant women with diabetes in pregnancy. GDm-Health enables remote monitoring of pregnant women to comply with social distancing guidance during the COVID-19 pandemic. GDm-Health helps this high-risk group monitor their condition and be managed by clinicians, safely at home. Clinicians use the GDm-Health desktop application to review readings - algorithms prioritise patients in greatest need. GDm-Health can be used at pre conception, diagnosed gestational diabetes and suspected gestational diabetes, throughout the pregnancy and post delivery until clinically necessary. GDm-Health is regulated, CE marked, HIPPA compliant and adopted broadly with the UK. GDm-Health comprises a free smartphone application that can connect to a blood glucose monitor via Bluetooth - patients input blood glucose readings, add notes and request callbacks if needed.

Our Discovery Sciences and Software Product divisions work together towards one goal: To connect patients, clinicians and researchers, which collectively help healthcare professionals deliver better patient care while curating vital data to support the next generation of medical research.

The Spect Ophthalmic Camera is a product consisting of an Apple iPhone, a mobile application (app), and an optical lens attachment and illumination source. The mobile app is accessible to users via the Apple App Store (Apple Inc.) for use on Spect issued iPhone devices. The Spect Ophthalmic Camera consists of a mechanical adaptor with a telescopic feature that houses a high-quality glass fundoscopic lens, and a white-light LED illumination source. The images are transferred and stored to a separate product, the Spect Ocular System, where a physician can retrieve and review the images.